Form 8-K12B/A - Notification that a class of securities of successor issuer is deemed to be registered pursuant to section 12(b): [Amend]
SEC Accession No. 0001140361-25-026049
Filing Date
2025-07-16
Accepted
2025-07-16 16:40:58
Documents
12
Period of Report
2025-07-01
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K12B/A ef20052082_8k12ba.htm   iXBRL 8-K12B/A 77345
  Complete submission text file 0001140361-25-026049.txt   222520

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA prok-20250701.xsd EX-101.SCH 3868
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE prok-20250701_lab.xml EX-101.LAB 23415
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE prok-20250701_pre.xml EX-101.PRE 17062
15 EXTRACTED XBRL INSTANCE DOCUMENT ef20052082_8k12ba_htm.xml XML 4564
Mailing Address 2000 FRONTIS PLAZA BLVD. SUITE 250 WINSTON-SALEM NC 27103
Business Address 2000 FRONTIS PLAZA BLVD. SUITE 250 WINSTON-SALEM NC 27103 336-999-7028
PROKIDNEY CORP. (Filer) CIK: 0001850270 (see all company filings)

EIN.: 981586514 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 8-K12B/A | Act: 34 | File No.: 001-40560 | Film No.: 251127861
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)